← All trials
NCT04658914
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2021
- Primary completion
- Jun 30, 2022
- Completion date
- Jun 30, 2023
- First posted
- Dec 9, 2020
- Last posted
- Dec 9, 2020
- Enrollment
- 720
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Centre for Infectious Disease Research in Zambia (CIDRZ)Lead sponsor
- Medical Research CouncilCollaborator
- Centre for Infectious Disease Research in Zambia (CIDRZ)Overall official - principal investigator
- PATHCollaborator
- Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
- University of LiverpoolCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.